FDA Watch is a twice-monthly, national podcast that provides an independent, non-partisan forum for discussing and understanding the latest developments, trends, and issues involving FDA. The podcast focuses on four core areas: pharmaceuticals and biologics; medical devices and diagnostics; food and dietary supplements; and cosmetics and personal care products, as well as on the overall direction of FDA regulation.
The podcast also will have bonus episodes to cover breaking news. Podcast guests analyze FDA regulations, guidances, and policy developments and engage in insightful and revealing conversations with host Wayne Pines, former FDA associate commissioner and author/editor of 16 books about FDA.
Subscribers to the podcast include regulatory affairs specialists, food and drug attorneys, policymakers, government officials, strategic planners, and IT and cybersecurity professionals.
About the Host
Wayne Pines

Wayne is a member of APCO Worldwide’s International Advisory Council and senior director of health care at APCO. He provides strategic counsel to health care and other clients facing crises or media, legislative, regulatory, or marketing challenges.
Wayne served ten years in senior positions at the United States Food and Drug Administration (FDA). He was FDA’s chief of consumer education and information, chief of press relations and associate commissioner for public affairs. He was also the chief media spokesman for the FDA for seven years and also was the founding editor of FDA Consumer magazine.
He has authored or edited a dozen books about crisis communication and the FDA, including books about the FDA approval process and its regulation of medical communications, crisis management and the history of the FDA. He has been widely published and is widely quoted in the media about FDA or health care issues and policies.
Wayne was a director and former chairman of the board of the MedStar Research Institute, which oversees research at ten hospitals in the Washington-Baltimore area. He is a founder, director and former president of the Alliance for a Stronger FDA, a coalition of organizations seeking more appropriated funding for FDA. He was previously a member of the Public Health Service’s first Task Force on AIDS Education; executive vice president of a large, international public relations agency; and chairman of a health care market research firm. He is a member of the Executive Committee of the Regional Board of the Anti-Defamation League.
Questions, Comments, or Suggestions?
We’d love to hear from you! Email info@FDAwatch.net or reach out to us on LinkedIn.

